This is an open-label, multicenter, single-arm, expanded access program (EAP) designed to provide MPDL3280A to patients with PD-L1-positive locally advanced or metastatic UBC that has progressed during or following a platinum-containing regimen.
Find Clinical Trials
To find clinical trials that focus on targeted therapies, use the pulldown menus below or enter a term in the search box.
Request a Consultation
To schedule a consultation with an oncologist at Dana-Farber/Brigham and Women's Cancer Center, please call one of our experienced appointment coordinators.
